Insecticides (India) Limited Sets Q2 FY27 Results for November 5
Key highlights
- Insecticides (India) is scheduled to announce Q2 and H1 FY27 results on November 5, 2026.
- Insecticides (India) will hold its Q2 and H1 FY27 earnings call at 5:00 pm IST on November 5, 2026.
- Insecticides (India) reported Q1 FY27 revenue of Rs 611 crore, up 43.47% quarter on quarter.
- Insecticides (India) reported Q1 FY27 net profit of Rs 43 crore, up 257.08% quarter on quarter.
powered by IRIS

Insecticides (India) Limited has scheduled its Q2 and H1 FY27 financial-results announcement for November 5, 2026, following Q1 FY27 revenue of Rs 611 crore. The board will consider unaudited standalone and consolidated results for the quarter and six months ended September 30, 2026, with an earnings call set for 5:00 pm IST.
Know Insecticides India inside out
Results, valuation, peers and who's buying, in one view.
When will Insecticides (India) announce Q2 FY27 results?
Insecticides (India) will announce its unaudited standalone and consolidated Q2 and H1 FY27 financial results on Thursday, November 5, 2026. The disclosure covers the three months and six months ended September 30, 2026, which represent the second quarter and first half of the financial year ending March 2027.
The company disclosed the schedule through an October 7, 2026 intimation issued under Regulation 30 of the SEBI Listing Obligations and Disclosure Requirements regulations. The board meeting is also expected to consider a possible interim dividend, according to the stated highlights. No dividend decision or financial outcome was included in the information provided before the scheduled meeting.
What will management discuss on the November 5 earnings call?
Insecticides (India) will hold an earnings conference call at 5:00 pm IST on November 5 to discuss the Q2 and H1 FY27 results. The call is scheduled for the same day as the financial-results announcement, allowing investors and analysts to hear management's discussion after the unaudited numbers are released.
The company has said that Managing Director Rajesh Kumar Aggarwal, Chief Financial Officer Sandeep Kumar Aggarwal, Chief Operating Officer Devendra Kumar Ray and Chief Marketing Officer Dushyant Sood will represent management on the call. The call notice provides India and international dial-in access and asks participants to pre-register.
For shareholders, the discussion may provide context on performance during the September quarter, including commentary on operations, sales conditions and financial trends. However, the company had not released the Q2 FY27 revenue, profit or margin figures in the material provided, so those details remain dependent on the November 5 announcement.
How did Insecticides (India) perform in Q1 FY27?
Insecticides (India) reported Q1 FY27 revenue of Rs 611 crore, according to the financial summary provided. Revenue was 43.47% higher quarter on quarter but 11.52% lower year on year, indicating a sequential increase from the preceding quarter alongside a lower comparison with the same period a year earlier.
Gross profit was reported at Rs 57 crore, up 258.45% quarter on quarter and down 25.08% year on year. Net profit stood at Rs 43 crore, rising 257.08% sequentially while declining 24.70% from a year earlier. A separate June-quarter reference in the source cited revenue of Rs 612 crore, operating profit of Rs 68 crore, an operating margin of 11.11%, and net profit of Rs 44 crore. The difference from the summary figures may reflect rounding or differing presentation of the reported data.
Got a follow-up? Ask IRIS
Why do the Q2 and H1 FY27 disclosures matter to investors?
The Q2 and H1 FY27 release matters because it will provide the next verified update on Insecticides (India)'s sales, profitability and operating performance after the June-quarter data. The first-half results will also allow investors to assess the combined performance of the June and September quarters rather than relying only on the Q1 FY27 snapshot.
The reported Q1 data showed a clear contrast between sequential and annual comparisons. Revenue, gross profit and net profit were higher than in the immediately preceding quarter, while each was lower than the year-earlier period. The Q2 release will establish whether those trends continued, changed or were affected by conditions specific to the September quarter.
The board's consideration of an interim dividend is another item relevant to shareholders. An interim dividend, if approved, would be formally disclosed after the board's decision along with applicable record-date and payment information. Until then, it remains a matter under consideration rather than a declared shareholder distribution.
What information remains unavailable before the results release?
Insecticides (India) had not disclosed official Q2 FY27 revenue, profit, margin or dividend figures in the provided announcements. The conference-call intimation confirms the timing of the results and the management participants, but it does not provide forecasts, guidance or estimates for the September 2026 quarter.
This distinction is important because an earlier preview referenced in the source stated that no verified estimate for the September-quarter revenue, profit or margins was available before the formal disclosure. Investors assessing the company before the announcement therefore have confirmed Q1 figures and a scheduled reporting date, but not the September-quarter financial outcome.
The company has previously made investor presentations, quarterly results, annual reports and earnings-call documents available through its investor resources. Its August 11, 2026 presentation related to the quarter ended June 30, 2026. The November 5 release and management call are the next identified events for updated financial information.
Conclusion
Insecticides (India) is set to report Q2 and H1 FY27 results on November 5, 2026, with management scheduled to address investors later that day. The available Q1 FY27 data shows revenue of Rs 611 crore, gross profit of Rs 57 crore and net profit of Rs 43 crore, with strong sequential increases but year-on-year declines across these measures.
Investors should watch for the unaudited standalone and consolidated financial statements, any board decision on an interim dividend, and management's comments during the 5:00 pm IST conference call. These disclosures are expected to provide the confirmed September-quarter figures and the first-half FY27 performance record.


